First Page | Document Content | |
---|---|---|
Date: 2012-12-22 03:08:03Oncology Docetaxel Oncologists Abiraterone Nicholas J. Vogelzang Medicine Chemistry Prostate cancer | Medivation Contacts: Patrick Machado Chief Business & Financial Officer[removed]Astellas Contacts:Add to Reading ListSource URL: www.astellas.comDownload Document from Source WebsiteFile Size: 67,54 KBShare Document on Facebook |
Non-Clinical Factors Influence treatment decisions November 2016 What we discovered… Despite the common understanding that oncologists’ treatment choices areDocID: 1t5H7 - View Document | |
Microsoft Outlook - Memo StyleDocID: 1qEWn - View Document | |
What are we doing? We need your help! The world of dog owners, veterinarians, oncologists and dog geneticists is about toDocID: 1q30v - View Document | |
CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment forDocID: 1pDeC - View Document | |
Quotes from CCMS Members and Interns “An understanding and appreciation Mini-Internship Chairs Souzan El-Eid, MDDocID: 1pqm1 - View Document |